Sanofi Goes Big On Asia Vaccines With Singapore Investment

Flexibility, Demand, Preparedness Cited

 
• By Ian Haydock

French giant makes its biggest single investment to date in Asia as it prepares to build up regional vaccine production capacity, in part to help prepare for future pandemics. 

Sanofi Singapore Vaccines Facility Event
L-R: Dr Beh Swan Gin, Chairman, Singapore Economic Development Board; Vincent Hingot, SVP, Head of Global Vaccines Industrial Affairs, Sanofi Pasteur; Eric Mansion, General Manager, Asia Zone, Sanofi Pasteur • Source: Sanofi

More from Focus On Asia

More from Scrip